You are here: Industry Insights > Breast Cancer

News List

Chemotherapy can spread breast cancer to lungs, study finds pharmafile
August 10, 2017
Researchers at Ohio State University have discovered that, as well as forming a key part of treatment strategies to fight breast cancer, chemotherapy can facilitate the spread of the disease to the lungs.
Parkway Pantai introduces new 3-D Mammography Technology in Singapore biospectrumasia
August 04, 2017
Parkway Pantai introduces new 3-D Mammography Technology in Singapore Parkway Pantai’s Mount Elizabeth Novena Hospital is the first recipient of the new GE 3-D Mammogram technology in ASEAN.
FDA approves new treatment to reduce the risk of breast cancer returning biospectrumasia
July 19, 2017
Nerlynx is the first extended adjuvant therapy, a form of therapy that is taken after an initial treatment to further lower the risk of the cancer coming back.
Mylan-Biocon’s breast cancer biosimilar gets US FDA nod financialexpress
July 14, 2017
Mylan and Biocon’s proposed biosimilar trastuzumab also is under review by regulatory authorities in Australia, Canada, Europe and other emerging markets
Genomic Health: Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role o b3cnewswire
July 13, 2017
Genomic Health today announced that the 15th St. Gallen International Breast Cancer Conference Expert Panel endorsed the use of genomic tests in early-stage breast cancer...
Many Women Mistaken on 'Side Effects' of Breast Cancer Drug drugs
June 30, 2017
Many Women Mistaken on 'Side Effects' of Breast Cancer Drug
Pfizer receives expanded Health Canada approval for Ibrance in HR+, HER2- metastatic breast cancer cphi-online
June 27, 2017
New indication supported by results of Phase III PALOMA-3 Trial of Ibrance in combination with fulvestrant.
SMC rejects Perjeta (pertuzumab) for NHS use for breast cancer europeanpharmaceuticalreview
June 19, 2017
The Scottish Medicines Consortium (SMC) has made a final decision to turn down Perjeta (pertuzumab) for routine NHS funding for first line use in women whose HER2-positive breast cancer has returned to the breast but is inoperable, or where it has spread
SMC rejects Perjeta (pertuzumab) for NHS use for breast cancer europeanpharmaceuticalreview
June 16, 2017
The Scottish Medicines Consortium (SMC) has made a final decision to turn down Perjeta (pertuzumab) for routine NHS funding for first line use in women whose HER2-positive breast cancer has returned to the breast but is inoperable
Genomic Health: New Data Show Important Role of Genomic Testing in Treatment of Older Breast Cancer b3cnewswire
June 07, 2017
Many patients 70 years or older had low rates of breast cancer recurrence and excellent survival when treated based on the biology of their tumor

Previous page 1 2 3 4 5 6 7 8 9 10 ... 26 27 Next page